This observation suggests that interventions aimed at elevating adiponectin levels could have an impact on reducing breast cancer risk, offering a promising avenue for future preventive strategies and emphasizing the importance of considering changes in biomarker levels over time rather than static baseline levels. Here, ADIPOQ is linked to breast cancer.